LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027

MARKET OUTLOOK
According to Triton Market Research, the Latin American immunohistochemistry market is anticipated to rise with a CAGR of 6.85% in estimated years of 2019-2027.
Argentina, Brazil, Chile, Cuba, Mexico and countries in rest of Latin America have been evaluated in this report on the Latin American market on immunohistochemistry.
Brazil boasts of a significant number of high-grade hospitals in the Latin America region, and attracts patients from bordering countries, mainly for heart-related disorders, cancer or cosmetic surgery. Also, the elderly population in the country is on the rise, which is expected to lead to an increase in healthcare spending because of the rise in age-related disorders. Data from the NCBI indicates that, after cardiac and cerebrovascular diseases, cancer is the second most common cause of death in Brazil. The rising prevalence of cancer expected to raise the demand for tissue diagnostics for treating and managing these conditions, thereby influencing the growth of the Brazilian immunohistochemistry market.
Cases of chronic diseases in Cuba have also witnessed a rise, which has led to a growth in the demand for immunohistochemistry reagents, antibodies as well as diagnostic procedure equipment in diagnostic laboratories and hospitals in the country. The rising cases of chronic diseases in Mexico have led to a growth in the demand for immunohistochemistry antibodies, reagents as well as diagnostic procedures equipment in hospitals and diagnostic laboratories in the country.
COMPETITIVE OUTLOOK
Few of the prime players in the market are Merck Millipore, Agilent Technologies, Inc., Siemens AG Healthcare, Cell Signaling Technology, Inc., Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories, Inc., Histologix, Bio SB, Danaher Corporation, BioGenex, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG and PerkinElmer, Inc.

TABLE OF CONTENT
1. LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. HISTORY OF IMMUNOHISTOCHEMISTRY
2.2. VALUE CHAIN OUTLOOK
2.3. KEY INSIGHTS
2.4. MARKET ATTRACTIVENESS MATRIX
2.5. MARKET DRIVERS
2.5.1. IN-VITRO TECHNOLOGICAL ADVANCEMENTS
2.5.2. INCREASING CANCER OCCURRENCE
2.5.3. SWELLING HEALTHCARE SPENDING
2.5.4. RISING GERIATRIC POPULATION
2.5.5. INCREASING USE OF POC TESTING
2.6. MARKET RESTRAINTS
2.6.1. RESTRICTIONS OF CLOSED SYSTEMS
2.6.2. REIMBURSEMENT ISSUES
2.7. MARKET OPPORTUNITIES
2.7.1. INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.7.2. TECHNOLOGICAL ADVANCEMENTS
2.8. MARKET CHALLENGES
2.8.1. STRINGENT REGULATIONS
2.8.2. HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY ANTIBODIES
3.1.2. SECONDARY ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE STAINING SYSTEMS
3.2.2. TISSUE MICROARRAYS
3.2.3. TISSUE PROCESSING SYSTEMS
3.2.4. SLIDE SCANNERS
3.2.5. OTHER EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL STAINS
3.3.2. BLOCKING SERA AND REAGENTS
3.3.3. CHROMOGENIC SUBSTRATES
3.3.4. FIXATION REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC SOLVENTS
3.3.7. PROTEOLYTIC ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS DISEASES
4.1.3. CARDIOVASCULAR DISEASE
4.1.4. AUTOIMMUNE DISEASES
4.1.5. DIABETES MELLITUS
4.1.6. NEPHROLOGICAL DISEASES
4.2. DRUG TESTING
5. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH INSTITUTES
5.3. OTHER END-USERS
6. IMMUNOHISTOCHEMISTRY (IHC) MARKET - LATIN AMERICA
6.1. COUNTRY ANALYSIS
6.1.1. BRAZIL
6.1.2. MEXICO
6.1.3. ARGENTINA
6.1.4. CHILE
6.1.5. CUBA
6.1.6. REST OF LATIN AMERICA
7. COMPETITIVE LANDSCAPE
7.1. ABBOTT LABORATORIES
7.2. ABCAM PLC
7.3. AGILENT TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD LABORATORIES, INC.
7.6. BIO SB
7.7. CELL SIGNALING TECHNOLOGY, INC.
7.8. DANAHER CORPORATION
7.9. F. HOFFMANN-LA ROCHE AG
7.10. HISTOLOGIX
7.11. MERCK MILLIPORE
7.12. PERKINELMER, INC.
7.13. SIEMENS AG HEALTHCARE
7.14. THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY








TABLE LIST
TABLE 1 LATIN AMERICA MARKET FOR IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTIONS
TABLE 7 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 11 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION
TABLE 13 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 16 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)








FIGURE LIST
FIGURE 1 LATIN AMERICA MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 LATIN AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA EQUIPMENT MARKET IN OTHER EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
FIGURE 23 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 24 LATIN AMERICA DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)
FIGURE 25 LATIN AMERICA DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 LATIN AMERICA DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 LATIN AMERICA DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 LATIN AMERICA DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 LATIN AMERICA DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 35 BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 36 HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($ BILLION)
FIGURE 37 MEXICO IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 38 HEALTHCARE SPENDING IN ARGENTINA 2014 AND 2040 ($ BILLION)
FIGURE 39 ARGENTINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 40 CHILE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 41 HEALTHCARE EXPENDITURE IN CHILE 2005-2016 (PERCENTAGE SHARE OF GDP)
FIGURE 42 HEALTHCARE SPENDING IN CUBA (2014 AND 2040)
FIGURE 43 CUBA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 44 REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)